Abstract
Summary: A properly functioning immune system is dependent on programmed cell death at virtually every stage of lymphocyte development and activity. This review addresses the phenomenon of activation‐induced cell death (AICD) in T lymphocytes, in which activation through the T‐cell receptor results in apoptosis. AICD can occur in a cell‐autonomous manner and is influenced by the nature of the initial T‐cell activation events. It plays essential roles in both central and peripheral deletion events involved in tolerance and homeostasis, although it is likely that different forms of AICD proceed via different mechanisms. For example, while AICD in peripheral T cells is often caused by the induction of expression of the death ligand, Fas ligand (CD95 ligand, FasL), it does not appear to be involved in AICD in thymocytes. This and other mechanisms of AICD are discussed. One emerging model that may complement other forms of AICD involves the inducible expression of FasL by nonlymphoid tissues in response to activated T lymphocytes. Induction of nonlymphoid FasL in this manner may serve as a sensing mechanism for immune cell infiltration, which contributes to peripheral deletion.
References
118
Referenced
497
10.1016/S1535-6108(02)00024-7
10.1038/337181a0
10.1038/339625a0
10.1126/science.2531464
10.4049/jimmunol.144.9.3326
/ J Immunol / Activation‐induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation by Shi YF (1990)10.4049/jimmunol.146.10.3340
10.1038/349245a0
10.1038/353858a0
10.1146/annurev.immunol.17.1.221
10.1007/BF01978763
10.1016/0092-8674(92)90123-T
10.1126/science.1378649
10.1038/359552a0
10.1038/359554a0
10.1038/373441a0
10.1038/373438a0
10.1038/373444a0
10.1084/jem.181.5.1673
10.4049/jimmunol.152.12.5624
10.1093/intimm/8.7.1017
10.1002/eji.1830230951
10.1006/jaut.1994.1055
10.1084/jem.181.1.71
10.1093/intimm/7.9.1451
10.1084/jem.183.2.431
10.1128/MCB.19.1.751
10.1016/S0960-9822(02)01140-5
10.1523/JNEUROSCI.21-19-07551.2001
10.1126/science.278.5341.1305
{'key': 'e_1_2_12_31_2', 'first-page': '26', 'article-title': 'Nonlymphoid Fas ligand in peptide‐induced peripheral lymphocyte deletion', 'volume': '26', 'author': 'Pinkoski MJ', 'year': '2002', 'journal-title': 'Proc Natl Acad Sci USA'}
/ Proc Natl Acad Sci USA / Nonlymphoid Fas ligand in peptide‐induced peripheral lymphocyte deletion by Pinkoski MJ (2002)10.1038/82725
10.4049/jimmunol.162.1.263
/ J Immunol / Fas/Fas ligand‐driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis by Stassi G (1999)10.1038/6509
10.1016/S1097-2765(00)80054-4
10.1038/nm0596-574
10.1038/sj.cdd.4400419
10.1073/pnas.94.15.8144
10.1126/science.285.5429.898
10.1038/35036608
-
WanYY DeGregoriJ.The survival of antigen stimulated T cells requires NFκB mediated inhibition of p73 expression.Immunity2003;18:331–342.
(
10.1016/S1074-7613(03)00053-0
) 10.1084/jem.188.11.2033
10.1016/1074-7613(94)90067-1
10.4049/jimmunol.147.2.466
/ J Immunol / Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice by Zhou T (1991)10.1016/S1074-7613(00)80549-X
10.1093/emboj/17.3.706
10.1038/ni894
10.1016/S1074-7613(00)80401-X
10.1038/ni0303-207
10.1038/415922a
10.1038/sj.cdd.4400329
10.1016/0092-8674(91)90361-2
10.1073/pnas.89.15.7003
10.1016/0092-8674(91)90362-3
10.1002/eji.1830261235
10.1016/S1074-7613(00)80306-4
10.1038/377348a0
10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X
10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3
10.1016/S1074-7613(02)00322-9
10.1084/jem.20020827
10.1126/science.286.5445.1735
10.4049/jimmunol.159.10.4737
/ J Immunol / Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma‐chain: defective Fas ligand expression in gamma‐chain‐deficient mice by Nakajima H (1997)10.1016/S1074-7613(00)80668-8
10.1038/35103104
10.1126/science.270.5239.1189
10.4049/jimmunol.169.9.4739
10.1126/science.274.5291.1363
10.1016/S0167-5699(98)01382-6
10.1073/pnas.94.8.3943
10.1038/nm0797-738
10.4049/jimmunol.162.1.518
/ J Immunol / Accelerated rejection of Fas ligand‐expressing heart grafts by Takeuchi T (1999)10.1172/JCI119173
10.1182/blood.V99.8.2940
10.1084/jem.191.7.1209
10.1016/1074-7613(94)90084-1
10.1038/35065111
10.1146/annurev.immunol.19.1.23
10.1074/jbc.M208167200
10.1016/S1074-7613(94)80016-2
10.1034/j.1600-0528.2002.017412.x
{'key': 'e_1_2_12_82_2', 'first-page': '184', 'article-title': 'Fas ligand‐deficient gld mice are more susceptible to graft‐versus‐host‐disease', 'volume': '70', 'author': 'Van Den Brink MR', 'year': '2000', 'journal-title': 'Transplantation'}
/ Transplantation / Fas ligand‐deficient gld mice are more susceptible to graft‐versus‐host‐disease by Van Den Brink MR (2000)10.1172/JCI8236
10.1084/jem.189.8.1195
10.1016/S0962-8924(97)01215-4
10.1126/science.281.5383.1680
10.1126/science.289.5488.2350
10.1126/science.281.5379.998
10.1128/MCB.19.9.5923
10.1074/jbc.274.3.1541
10.1016/S1074-7613(00)80566-X
10.1084/jem.180.6.2413
10.1074/jbc.275.13.9767
10.1016/S0960-9822(00)00727-2
10.1084/jem.189.2.231
10.1046/j.1365-2613.1999.00106.x
10.1016/S1074-7613(00)80660-3
10.4049/jimmunol.158.10.4602
/ J Immunol / Regulation of CD95 (Fas) ligand expression by TCR‐mediated signaling events by Latinis KM (1997)10.1093/emboj/19.17.4783
10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.0.CO;2-B
10.1074/jbc.272.50.31427
10.4049/jimmunol.161.3.1078
/ J Immunol / A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes by Norian LA (1998)10.1074/jbc.274.12.7756
10.1128/MCB.18.7.3744
10.1074/jbc.274.5.3222
10.1016/S1074-7613(00)80182-X
10.1093/intimm/6.10.1545
10.1084/jem.185.10.1837
10.1016/S0166-2236(98)01343-5
10.1146/annurev.immunol.16.1.225
10.1016/S0092-8674(02)00703-1
10.1074/jbc.274.2.987
10.1038/sj.cdd.4400611
10.4049/jimmunol.160.1.134
10.1084/jem.190.2.253
10.1074/jbc.275.14.10023
10.1016/S0092-8674(00)80595-4
10.1128/MCB.22.2.680-691.2002
10.4049/jimmunol.166.2.1028
Dates
Type | When |
---|---|
Created | 22 years, 3 months ago (May 12, 2003, 11:23 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 13, 2023, 7:44 p.m.) |
Indexed | 1 week, 1 day ago (Aug. 22, 2025, 12:45 a.m.) |
Issued | 22 years, 3 months ago (May 12, 2003) |
Published | 22 years, 3 months ago (May 12, 2003) |
Published Online | 22 years, 3 months ago (May 12, 2003) |
Published Print | 22 years, 2 months ago (June 1, 2003) |
@article{Green_2003, title={Activation‐induced cell death in T cells}, volume={193}, ISSN={1600-065X}, url={http://dx.doi.org/10.1034/j.1600-065x.2003.00051.x}, DOI={10.1034/j.1600-065x.2003.00051.x}, number={1}, journal={Immunological Reviews}, publisher={Wiley}, author={Green, Douglas R. and Droin, Nathalie and Pinkoski, Michael}, year={2003}, month=may, pages={70–81} }